News

Selective sFlt 1 apheresis reduced circulating sFlt 1 levels in women with very preterm preeclampsia while maintaining maternal and fetal stability.

Experts have identified two candidate vaccines for Bundibugyo virus, which could take months to get to clinical trial. Instead, they remain focused on affected communities.

Long-term data presented at EuroPCR 2026 showed similar mortality rates after PCI or CABG for left main coronary artery disease.

Systemic lupus erythematosus was associated with lower second delivery rates and recurrent pregnancy complications in a nationwide study.

Combining ixekizumab with tirzepatide improved skin clearance and weight loss in adults with psoriasis and obesity in a Phase 3b trial.

New UKHSA report highlights lower testing uptake, PrEP access, and later diagnoses in Black African communities.

Quantitative MRCP may improve risk prediction and clinical trial development in primary sclerosing cholangitis, an international study suggests.

Neuroimaging use rose across Europe between 2015 and 2022, with CT and MRI volumes increasing more than 40%, alongside marked regional disparities across 29 countries.